Evidence map›Paper›PMID 32061110›Full record

ReviewJournal of pineal research2020

Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies.

Keisaku Sato, Fanyin Meng, Heather Francis, Nan Wu, Lixian Chen, Lindsey Kennedy, Tianhao Zhou, Antonio Franchitto, Paolo Onori, Eugenio Gaudio and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of pineal research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Circadian Effects of Melatonin Receptor-Targeting Molecules In Vitro.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. IPCellular & molecular biology letters · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Keisaku SatoDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.ORCID https://orcid.org/0000-0001-5380-8001
Fanyin MengDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.
Heather FrancisDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.
Nan WuDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.
Lixian ChenDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.
Lindsey KennedyDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.
Tianhao ZhouDepartment of Medical Physiology, Texas A&M University, Bryan, TX, USA.
Antonio FranchittoEleonora Lorillard Spencer Cenci Foundation, Rome, Italy.
Paolo OnoriDepartment of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Rome, Italy.
Eugenio GaudioDepartment of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Rome, Italy.
Shannon GlaserDepartment of Medical Physiology, Texas A&M University, Bryan, TX, USA.
Gianfranco AlpiniDivision of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA.ORCID https://orcid.org/0000-0002-6658-3021
Indiana University Indianapolis · USRichard L. Roudebush VA Medical Center · USSapienza University of Rome · ITTexas A&M University · US

Funding

GROWTH REGULATION OF THE INTRAHEPATIC BILIARY TREER01DK054811 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2000 to 2021
$3.8M
The Paracrine Regulation of Mast Cells During Biliary/Cholangiocyte Repair and DamageR01DK108959 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI FRANCIS, HEATHER L · 2016 to 2024
$2.5M
Regulation of Bile Duct Growth in Bile Duct Ligated RatsR01DK062975 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2005 to 2014
$1.9M
Role of Sensory Neuropeptides in the Regulation of Biliary FunctionR01DK076898 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2008 to 2016
$1.8M
The Role of Stem Cell Derived Microvesicles in Cholestatic Liver InjuryR01DK107310 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2015 to 2019
$1.7M
Mechanisms of mast cell/cholangiocyte regulation of non-alcoholic fatty liver disease progressionR01DK119421 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI FRANCIS, HEATHER L · 2019 to 2022
$1.4M
Neuroendocrine Regulation of Biliary Growth and FibrosisR01DK110035 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2017 to 2020
$1.2M
Regulation of biliary growth and fibrosis by melatoninR01DK115184 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2017 to 2020
$1.2M
REGULATION OF CELLULAR SENESCENCE BY NON-CODING RNAS IN ALCOHOLIC LIVER INJURYR21AA025997 · NIAAA · SCOTT AND WHITE MEMORIAL HOSPITAL · PI ALPINI, GIANFRANCO D, MENG, FANYIN · 2017 to 2018
$435k
Role of stem cell derived microvesicles in alcoholic liver injuryR21AA025157 · NIAAA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, MENG, FANYIN · 2017 to 2018
$350k
BLR&D Research Career Scientist AwardIK6BX004601 · VA · RLR VA MEDICAL CENTER · PI ALPINI, GIANFRANCO D · 2019 to 2025
–
Functional characters of non-coding RNAs in alcoholic liver injuryI01BX001724 · VA · RLR VA MEDICAL CENTER · PI MENG, FANYIN · 2012 to 2024
–
BLRD VA I01 BX000574BLRD VA I01 BX001724BLRD VA I01 BX002192BLRD VA I01 BX003031BLRD VA IK6 BX004601NIAAA NIH HHS R21 AA025157NIAAA NIH HHS R21 AA025997NIDDK NIH HHS R01 DK054811NIDDK NIH HHS R01 DK062975NIDDK NIH HHS R01 DK076898NIDDK NIH HHS R01 DK107310NIDDK NIH HHS R01 DK108959NIDDK NIH HHS R01 DK110035NIDDK NIH HHS R01 DK115184NIDDK NIH HHS R01 DK119421NIH HHS DK062975NIH HHS DK108959NIH HHS DK115184, DK054811, DK076898, DK107310, DK110035NIH HHS DK119421NIH National Institute on Alcohol Abuse and Alcoholism Grants AA025157NIH National Institute on Alcohol Abuse and Alcoholism Grants AA025997United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service 1I01BX001724United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service 1I01BX003031United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service 5I01BX000574United States Department of Veteran's Affairs Biomedical Laboratory Research and Development Service 5I01BX002192Veterans Affairs Merit Awards 1I01BX003031, 4I01BX000574, 1I01BX001724
6 · The paper itself

Abstract

Circadian rhythms and clock gene expressions are regulated by the suprachiasmatic nucleus in the hypothalamus, and melatonin is produced in the pineal gland. Although the brain detects the light through retinas and regulates rhythms and melatonin secretion throughout the body, the liver has independent circadian rhythms and expressions as well as melatonin production. Previous studies indicate the association between circadian rhythms with various liver diseases, and disruption of rhythms or clock gene expression may promote liver steatosis, inflammation, or cancer development. It is well known that melatonin has strong antioxidant effects. Alcohol drinking or excess fatty acid accumulation produces reactive oxygen species and oxidative stress in the liver leading to liver injuries. Melatonin administration protects these oxidative stress-induced liver damage and improves liver conditions. Recent studies have demonstrated that melatonin administration is not limited to antioxidant effects and it has various other effects contributing to the management of liver conditions. Accumulating evidence suggests that restoring circadian rhythms or expressions as well as melatonin supplementation may be promising therapeutic strategies for liver diseases. This review summarizes recent findings for the functional roles and therapeutic potentials of circadian rhythms and melatonin in liver diseases.

Indexed as

Liver DiseasesAnimalsCircadian RhythmHumansMelatoninMelatonincircadian rhythmsclock genesliver fibrosisliver steatosismelatoninnonalcoholic fatty liver diseasereactive oxygen species

Identifiers

PMID32061110
PMCPMC8682809
OpenAlexW3006647520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.